SGP
SpyGlass Pharma, Inc.
NASDAQ · Healthcare · Biotechnology · US
$24.60
+2.50%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- -$0.66
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- -$0.59
- EPS estimate
- -$0.51
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -316.0%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $38
- PT range
- $37 – $39
- Analysts
- 2
1 Buy1 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.51 | -$0.59 | Miss -14.69% | — |
| May 14, 2026 | -$0.50 | -$0.69 | Miss -37.15% | — |
| Mar 26, 2026 | -$0.57 | -$5.72 | Miss -896.13% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026